Vestagen and Dove Professional Apparel Sign Licensing and Distribution Agreement for
Vestagen and Dove Professional Apparel Sign Licensing and Distribution Agreement for VESTEX®-Protected Fabrics
-- First Licensing Agreement for Protective Garments Targeting Nursing Schools Made from Vestagen's VESTEX® Fabric that Is Clinically Proven to Reduce Acquisition and Retention of Dangerous Contaminants --
-- Dove Receives License to Manufacture and Market Multiple Lines of Its Own VESTEX-Protected Brand --
-- Vestagen CEO Bill Bold to Present at MedCity INVEST Conference on April 12 --
Separately, Vestagen announced that CEO Bill Bold will present an overview of the company's strategy and progress at the MedCity INVEST Conference in Chicago on the afternoon of April 12, 2016. For more information, see http://events.medcitynews.com/invest.
About Vestagen Vestagen develops and markets advanced performance textile products and technologies. Vestagen has developed VESTEX®, which represents a new class of technology-based, active barrier protective fabrics combining antimicrobial, liquid repellent and breathability properties. VESTEX uniforms and scrubs are designed to protect healthcare workers and their patients from dangerous contaminants. They are clinically proven to prevent or reduce the acquisition and retention of contaminants on clothing and are comfortable, durable and affordable. For more information, visit vestagen.com.
About Dove Dove Professional Apparel was founded in 1985 by an ICU nurse/nurse educator and a teacher specializing in textiles. The uniforms the founders created combined usefulness with style, with the result being a no-nonsense line of fashionable yet durable uniforms for student nurses who are often frustrated by the lack of well made, nice looking garment options. Dove's goals are to provide the highest quality, best looking, long lasting custom uniforms, along with an easy ordering process for customers and a complete solution for school administrators. For more information visit doveapparel.com.